Cited by 709Ovarian function and disordersReproductive Biology and FertilitySexual Differentiation and Disorders

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Elevated Serum Level of Anti-Mullerian Hormone in Patients with Polycystic Ovary Syndrome: Relationship to the Ovarian Follicle Excess and to the Follicular Arrest

Pigny, Pascal, Merlen, Emilie, Robert, Yann, Cortet-Rudelli, Christine, Decanter, Christine, Jonard, Sophie, Dewailly, Didier·2003·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jc.2003-030727

Open this paper in CoChat — free account

Abstract

The serum level of anti-Mullerian hormone (AMH), a product from granulosa cells involved in follicle growth, has been shown to correlate tightly with the small antral follicle number (FN) at ultrasonography (U/S) in women who do not have polycystic ovary syndrome (PCOS). Because PCOS is associated with a 2- to 3-fold increase in growing FN, we investigated whether an increased AMH serum level correlates to other hormonal and/or U/S features of PCOS. Serum AMH has been assayed in 104 women (59 symptomatic PCOS, 45 controls) between d 2 and 7 after the last either spontaneous or progestin-induced (in PCOS) menstrual period. Mean serum AMH level was markedly increased in the PCOS group (47.1 +/- 22.9 vs. 20.8 +/- 11.6 pmol/liter in controls; P < 0.0001), an increase in the same order of magnitude as the one of the FN in the 2- to 5-mm range at U/S (12.8 +/- 8.3 vs. 4.8 +/- 1.9; P < 0.0001, respectively). The ratio AMH/FN was similar between the two groups (4.8 +/- 3.4 vs. 4.8 +/- 2.9; P = 0.55). By simple regression, both in PCOS and controls, the AMH level was positively related to the 2- to 5-mm FN at U/S (P < 0.0001 and P < 0.03, respectively), but not to the 6- to 9-mm FN, and was negatively correlated to the serum FSH level (P < 0.02 and P < 0.04, respectively). AMH was also positively related to the serum testosterone and androstenedione levels, in PCOS exclusively (P < 0.0005 and <0.002, respectively). No relationship was found between AMH and age, serum estradiol, inhibin B, and LH levels in both groups. After multiple regression only the 2- to 5-mm FN remained significantly related to AMH in PCOS whereas testosterone, androstenedione, and FSH were no longer. In conclusion, the assay of the serum AMH may represent an important breakthrough in the diagnosis and in the understanding of PCOS. Our data suggest that the increase of AMH serum level in PCOS is the consequence of the androgen-induced excess in small antral FN and that each follicle produces a normal amount of AMH. We hypothesize that an increased AMH tone within the cohort could be involved in the follicular arrest of PCOS, by interacting negatively with FSH at the time of selection.

Integrity signals

Registry

Crossref · 10.1210/jc.2003-030727

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Polycystic Ovary Syndrome
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve.
van Rooij, I., Broekmans, F., Velde, E. T., Fauser, B. C., Bancsi, L., de Jong, F. D., & Themmen, A. (2002) · Human Reproduction · doi:10.1093/humrep/17.12.3065 · Cited by 1,021
Antimüllerian hormone serum levels: a putative marker for ovarian aging
de Vet, A., Laven, J. S. E., de Jong, F. H., Themmen, A. P. N., & Fauser, B. C. J. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02993-4 · Cited by 886
Anti-Mullerian Hormone Inhibits Initiation of Primordial Follicle Growth in the Mouse Ovary
Durlinger, A. L. L., Gruijters, M. J. G., Kramer, P., Karels, B., Ingraham, H. A., Nachtigal, M. W., Uilenbroek, J. T. J., Grootegoed, J. A., & Themmen, A. P. N. (2002) · Endocrinology · doi:10.1210/endo.143.3.8691 · Cited by 842
Anti-Mullerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary
Durlinger, A. L. L., Gruijters, M. J. G., Kramer, P., Karels, B., Kumar, T. R., Matzuk, M. M., Rose, U. M., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., et al. (2001) · Endocrinology · doi:10.1210/endo.142.11.8486 · Cited by 772
Regulation of ovarian function: the role of anti-Mullerian hormone
Durlinger, A. L. L., Visser, J. A., & Themmen, A. P. N. (2002) · Reproduction · doi:10.1530/rep.0.1240601 · Cited by 766
Androgens stimulate early stages of follicular growth in the primate ovary
Vendola, K. A., Zhou, J., Adesanya, O. O., Weil, S. J., & Bondy, C. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2081 · Cited by 712
Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.
Fanchin, R., Schonauer, L. M., Righini, C., Guibourdenche, J., Frydman, R., & Taieb, J. (2003) · Human Reproduction · doi:10.1093/humrep/deg042 · Cited by 649
Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis.
Billig, H., Furuta, I., & Hsueh, A. J. W. (1993) · Endocrinology · doi:10.1210/endo.133.5.8404672 · Cited by 556
Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles
Seifer, D. B., MacLaughlin, D. T., Christian, B. P., Feng, B., & Shelden, R. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03201-0 · Cited by 494

Flagged first, then by citations

Show all 28 references

Sorted by citations

Items 101–200 of 709

Anti-Müllerian hormone: clinical insights into a promising biomarker of ovarian follicular status
Feyereisen, E., Lozano, D. H. M., Taieb, J., Hesters, L., Frydman, R., & Fanchin, R. R. F. (2006) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61081-4 · Cited by 103
The role of anti‐Müllerian hormone in female fertility and infertility – an overview
Grynnerup, A. G.-A., Lindhard, A., & Sørensen, S. (2012) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2012.01471.x · Cited by 101
Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone
Villarroel, C., Merino, P. M., Lopez, P., Eyzaguirre, F. C., Velzen, A. V., Íñiguez, G., & Ethel Codner, D. (2011) · Human Reproduction · doi:10.1093/humrep/der223 · Cited by 101
The role of AMH in anovulation associated with PCOS: a hypothesis
Homburg, R., & Crawford, G. (2014) · Human Reproduction · doi:10.1093/humrep/deu076 · Cited by 100
Role of Oxidative Stress in Polycystic Ovary Syndrome
Lee, J. Y., Baw, C., Gupta, S., Aziz, N., & Agarwal, A. K. (2010) · Current Women s Health Reviews · doi:10.2174/157340410791321336 · Cited by 99
Is Anti-Müllerian Hormone Associated With Fecundability? Findings From the EAGeR Trial
Zarek, S. M., Mitchell, E. M., Sjaarda, L. A., Mumford, S. L., Silver, R. M., Stanford, J. B., Galai, N., White, M. V., Schliep, K. C., DeCherney, A. H., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2474 · Cited by 103
The value of measuring anti-Mullerian hormone in women with anovulatory polycystic ovary syndrome undergoing laparoscopic ovarian diathermy
Amer, S. A. K. S., Li, T. C., & Ledger, W. J. (2009) · Human Reproduction · doi:10.1093/humrep/dep271 · Cited by 99
Normal serum concentrations of anti-Müllerian hormone in women with regular menstrual cycles
Marca, A. L., Sighinolfi, G., Giulini, S., Traglia, M., Argento, C., Sala, C. F., Masciullo, C., Volpe, A., & Toniolo, D. (2010) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2010.05.009 · Cited by 98
Polycystic ovary syndrome: Understanding the role of the brain
Moore, A. M., & Campbell, R. E. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.05.002 · Cited by 100
Clinical uses of anti-Müllerian hormone assays: pitfalls and promises
Streuli, I., Fraisse, T., Chapron, C., Bijaoui, G., Bischof, P., & de Ziegler, D. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.10.067 · Cited by 96
Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome
Das, M., Gillott, D. J., Sarıdoğan, E., & Djahanbakhch, O. (2008) · Human Reproduction · doi:10.1093/humrep/den185 · Cited by 97
Serum anti-Müllerian hormone expression in women with premature ovarian failure
Méduri, G., Massin, N., Guibourdenche, J., Bachelot, A., Fiori, O., Kuttenn, F., Misrahi, M., & Touraine, P. A. (2006) · Human Reproduction · doi:10.1093/humrep/del346 · Cited by 95
Gonadal soma controls ovarian follicle proliferation through Gsdf in zebrafish
Yan, Y., Desvignes, T., Bremiller, R., WILSON, C. A., Dillon, D. M., High, S. K., Draper, B. W., Buck, C. L., & Postlethwait, J. H. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24579 · Cited by 95
Is polycystic ovary syndrome an exception for reproductive aging?
Ramezani Tehrani, F., Solaymani-Dodaran, M., Hedayati, M., & Azizi, F. (2010) · Human Reproduction · doi:10.1093/humrep/deq088 · Cited by 111
Multicenter analytical performance evaluation of a fully automated anti-Müllerian hormone assay and reference interval determination
Anckaert, E., Öktem, M., Thies, A., Cohen-Bacrie, M., Daan, N. M. P., Schiettecatte, J., Müller, C., Topçu, D. İ., Gröning, A., Ternaux, F., et al. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.10.008 · Cited by 91
Biological variability in serum anti-Mullerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women
Kissell, K., Danaher, M. R., Schisterman, E. F., Wactawski‐Wende, J., Ahrens, K. A., Schliep, K. C., Perkins, N. J., Sjaarda, L. A., Weck, J., & Mumford, S. L. (2014) · Human Reproduction · doi:10.1093/humrep/deu142 · Cited by 90
Serum anti-mullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills
Arbo, E., Vettori, D. V., Jiménez, M. F., de Freitas, F. M., Lemos, N. A., & Cunha‐Filho, J. S. (2007) · Human Reproduction · doi:10.1093/humrep/dem258 · Cited by 88
Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes
Sova, H., Unkila‐Kallio, L., Tiitinen, A. E., Hippeläinen, M., Perheentupa, A. H., Tinkanen, H., Puukka, K. S., Bloigu, R., Piltonen, T., Tapanainen, J. S., et al. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1559807 · Cited by 90
Endocrine Disrupting Chemicals in Polycystic Ovary Syndrome: The Relevant Role of the Theca and Granulosa Cells in the Pathogenesis of the Ovarian Dysfunction
Józkowiak, M., Piotrowska‐Kempisty, H., Kobylarek, D., Gorska, N., Mozdziak, P. E., Kempisty, B., Rachoń, D., & Spaczyński, R. (2022) · Cells · doi:10.3390/cells12010174 · Cited by 96
A Functional Anti-Müllerian Hormone Gene Polymorphism Is Associated with Follicle Number and Androgen Levels in Polycystic Ovary Syndrome Patients
Kevenaar, M. E., Laven, J. S. E., Fong, S. L., Uitterlinden, A. G., de Jong, F. H., Themmen, A. P. N., & Visser, J. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2205 · Cited by 88
Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels
Singer, T., Barad, D. H., Weghofer, A., & Gleicher, N. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.03.034 · Cited by 88
Anti-Müllerian hormone (AMH): Regulator and marker of ovarian function
van Houten, E. L. A. F., Themmen, A. P. N., & Visser, J. A. (2010) · Annales d Endocrinologie · doi:10.1016/j.ando.2010.02.016 · Cited by 88
The effect of weight loss on anti-Mullerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment
Thomson, R. L., Buckley, J. D., Moran, L., Noakes, M., Clifton, P. M., Norman, R. J., & Brinkworth, G. D. (2009) · Human Reproduction · doi:10.1093/humrep/dep101 · Cited by 87
Pathological pulses in PCOS
Coyle, C., & Campbell, R. E. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110561 · Cited by 89
Antimüllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy
Caanen, M. R., Soleman, R. S., Kuijper, E. A. M., Kreukels, B. P. C., Roo, C. D., Tilleman, K., Sutter, P. D., van Trotsenburg, M. A. A., Broekmans, F. J., & Lambalk, C. B. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.02.003 · Cited by 87
Effects of a Holistic Yoga Program on Endocrine Parameters in Adolescents with Polycystic Ovarian Syndrome: A Randomized Controlled Trial
Nidhi, R., Padmalatha, V., Nagarathna, R., & Ram, A. (2012) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2011.0868 · Cited by 82
The association between circulating levels of antimüllerian hormone and follicle number, androgens, and menstrual cycle characteristics in young women
Kristensen, S. L., Ramlau‐Hansen, C. H., Andersen, C. Y., Ernst, E., Olsen, S. F., Bonde, J. P., Vested, A., & Toft, G. V. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.12.017 · Cited by 81
Ovarian Expression of Adipokines in Polycystic Ovary Syndrome: A Role for Chemerin, Omentin, and Apelin in Follicular Growth Arrest and Ovulatory Dysfunction?
Bongrani, A., Mellouk, N., Ramé, C., Cornuau, M., Guérif, F., Froment, P., & Dupont, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153778 · Cited by 82
Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis
Fong, S. L., Laven, J. S. E., Duhamel, A., & Dewailly, D. (2017) · Human Reproduction · doi:10.1093/humrep/dex226 · Cited by 81
Per-follicle measurements indicate that anti-müllerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status
Fanchin, R. R. F., Louafi, N., Lozano, D. H. M., Frydman, N., Frydman, R., & Taieb, J. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.01.115 · Cited by 80
Clinical and biochemical discriminants between functional hypothalamic amenorrhoea (FHA) and polycystic ovary syndrome (PCOS)
Phylactou, M., Clarke, S. A., Patel, B., Baggaley, C., Jayasena, C. N., Kelsey, T., Comninos, A. N., Dhillo, W. S., & Abbara, A. (2020) · Clinical Endocrinology · doi:10.1111/cen.14402 · Cited by 77
Differences of the association of anti-Müllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome
Woo, H., Kim, K. H., Rhee, E., Park, H., & Lee, M. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0055 · Cited by 78
Age-related distribution of basal serum AMH level in women of reproductive age and a presumably healthy cohort
Shebl, O. J., Ebner, T., Sir, A., Schreier-Lechner, E., Mayer, R. B., TEWS, G., & Sommergruber, M. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.09.012 · Cited by 78
Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period
Sowers, M. R., McConnell, D. S., Yosef, M., Jannausch, M. L., Harlow, S. D., & Randolph, J. F. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05523.x · Cited by 78
Changes in Serum Anti-Mullerian Hormone Level during Low-Dose Recombinant Follicular-Stimulating Hormone Therapy for Anovulation in Polycystic Ovary Syndrome
Catteau-Jonard, S., Pigny, P., Reyss, A.-C., Decanter, C., Poncelet, É., & Dewailly, D. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0868 · Cited by 78
New biomarkers for diagnosis and management of polycystic ovary syndrome
Karakas, S. E. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.06.009 · Cited by 81
The Predictive Value of Circulating Anti-Müllerian Hormone in Women With Polycystic Ovarian Syndrome Receiving Clomiphene Citrate: A Prospective Observational Study
Mahran, A., Abdelmeged, A. N., El-Adawy, A. R., Eissa, M. K., Shaw, R. W., & Amer, S. A. K. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2193 · Cited by 77
Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the rotterdam criteria
Jamil, A. S., Alalaf, S. K., Al-Tawil, N. G., & Al-Shawaf, T. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3889-5 · Cited by 73
The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients
Chang, C. L., Huang, S. Y., Hsu, Y. C., Chin, T. H., & Soong, Y. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-42061-9 · Cited by 80
Obesity-Related Hypogonadism in Women
Eng, P. C., Phylactou, M., Qayum, A., Woods, C., Lee, H., Aziz, S., Moore, B., Miras, A. D., Comninos, A. N., Tan, T., et al. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad027 · Cited by 83
Serum Anti-Mullerian Hormone Concentrations Are Elevated in Oligomenorrheic Girls without Evidence of Hyperandrogenism
Park, A. S., Lawson, M. A., Chuan, S. S., Oberfield, S. E., Hoeger, K. M., Witchel, S. F., & Chang, R. J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2106 · Cited by 77
AMH as the primary marker for fertility
Dewailly, D., & Laven, J. S. E. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0373 · Cited by 76
Serum Anti-Mullerian Hormone Concentrations Are Not Altered by Acute Administration of Follicle Stimulating Hormone in Polycystic Ovary Syndrome and Normal Women
Wachs, D. S., Coffler, M. S., Malcom, P. J., & Chang, R. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2425 · Cited by 75
Improvement Effect of Metformin on Female and Male Reproduction in Endocrine Pathologies and Its Mechanisms
Shpakov, A. O. (2021) · Pharmaceuticals · doi:10.3390/ph14010042 · Cited by 83
A review of the hormones involved in the endocrine dysfunctions of polycystic ovary syndrome and their interactions
Emanuel, R. H. K., Roberts, J., Docherty, P. D., Lunt, H., Campbell, R. E., & Möller, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1017468 · Cited by 87
Anti-Müllerian hormone and polycystic ovary syndrome
Bhide, P., & Homburg, R. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.03.004 · Cited by 77
Impact of laparoscopic ovarian drilling on anti-Müllerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women with anovulatory polycystic ovary syndrome
El-Mashad, A. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.03.093 · Cited by 73
Polycystic ovary syndrome and anti‐Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins
Cassar, S., Teede, H. J., Moran, L., Joham, A. E., Harrison, C. L., Strauss, B. J., & Stepto, N. K. (2014) · Clinical Endocrinology · doi:10.1111/cen.12557 · Cited by 75
Exposure to polycyclic aromatic hydrocarbons and risk for premature ovarian failure and reproductive hormones imbalance
Ye, X., Pan, W., Li, C., Ma, X., Yin, S., Zhou, J., & Liu, J. (2020) · Journal of Environmental Sciences · doi:10.1016/j.jes.2019.12.015 · Cited by 72
Markers of ovarian reserve as predictors of future fertility
Harris, B. S., Jukic, A. M. Z., Truong, T., Nagle, C. T., Erkanli, A., & Steiner, A. Z. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.10.014 · Cited by 72
RETRACTED: Effect of Obesity on Parameters of Ovarian Reserve in Premenopausal Women
El-Halawaty, S., ElKattan, E. A., Azab, H., ElGhamry, N., & Al-Inany, H. G. (2010) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34573-x · Cited by 73
Retracted
Diagnosis of Polycystic Ovary Syndrome: AMH in combination with clinical symptoms
Sahmay, S., Aydin, Y., Oncul, M., & Senturk, L. M. (2014) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-013-0149-0 · Cited by 71
Anti-Müllerian Hormone and Its Clinical Use in Pediatrics with Special Emphasis on Disorders of Sex Development
Johansen, M. L., Hagen, C. P., Johannsen, T. H., Main, K. M., Picard, J., Jørgensen, A., Meyts, E. R., & Juul, A. (2013) · International Journal of Endocrinology · doi:10.1155/2013/198698 · Cited by 71
The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia
Panidis, D., Georgopoulos, N. A., Piouka, A., Katsikis, I., Saltamavros, A. D., Decavalas, G., & Diamanti‐Kandarakis, E. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.507283 · Cited by 71
A Hormone That Lost Its Receptor: Anti-Müllerian Hormone (AMH) in Zebrafish Gonad Development and Sex Determination
Yan, Y., Batzel, P., Titus, T. A., Sydes, J., Desvignes, T., Bremiller, R., Draper, B. W., & Postlethwait, J. H. (2019) · Genetics · doi:10.1534/genetics.119.302365 · Cited by 76
Elevated serum levels of anti‐Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome
Şahmay, S., Atakul, N., Mathyk, B. A., AYDIN, Y. M., İmamoğlu, M., & Seyisoğlu, H. (2013) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12247 · Cited by 70
An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options
Islam, H., Masud, J., Islam, Y. N., & Haque, F. K. M. (2022) · Women s Health · doi:10.1177/17455057221117966 · Cited by 98
Polycystic Ovary-Like Abnormalities (PCO-L) in Women with Functional Hypothalamic Amenorrhea
Robin, G., Gallo, C., Catteau-Jonard, S., Maunoury-Lefebvre, C., Pigny, P., Duhamel, A., & Dewailly, D. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1836 · Cited by 69
Circulating antimüllerian hormone and steroid hormone levels remain high in pregnant women with polycystic ovary syndrome at term
Piltonen, T., Giacobini, P., Edvinsson, Å., Hustad, S., Lager, S., Morin-Papunen, L. C., Tapanainen, J. S., Poromaa, I. S., & Arffman, R. K. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.11.028 · Cited by 68
Polycystic Ovarian Syndrome: A Complex Disease with a Genetics Approach
Nautiyal, H., Imam, S. S., Alshehri, S., Ghoneim, M. M., Afzal, M., Alzarea, S. I., Güven, E., Al-Abbasi, F. A., & Kazmi, I. A. (2022) · Biomedicines · doi:10.3390/biomedicines10030540 · Cited by 80
Comparability of antimüllerian hormone levels among commercially available immunoassays
Su, H.-C. I., Sammel, M. D., Homer, M. V., Bui, K., Haunschild, C., & Stanczyk, F. Z. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.046 · Cited by 68
The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome
Dilaver, N., Pellatt, L. J., Jameson, E., Ogunjimi, M., Bano, G., Homburg, R., Mason, H. D., & Rice, S. (2019) · Human Reproduction · doi:10.1093/humrep/dez214 · Cited by 68
The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome
Alebić, M. Š., Stojanović, N., Duhamel, A., & Dewailly, D. (2015) · Human Reproduction · doi:10.1093/humrep/dev131 · Cited by 67
Clinical application of serum anti-Müllerian hormone in women
Oh, S. R., Choe, S. Y., & Cho, Y. J. (2019) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2019.46.2.50 · Cited by 68
Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome
Diamanti‐Kandarakis, E., Piouka, A., Livadas, S., Piperi, C., Katsikis, I., Papavassiliou, A. G., & Panidis, D. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0510 · Cited by 69
Ovarian reserve in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling
Weerakiet, S., Lertvikool, S., Tingthanatikul, Y., Wansumrith, S., Leelaphiwat, S., & Jultanmas, R. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701485212 · Cited by 67
Hypogonadism in females with Prader–Willi syndrome from infancy to adulthood: variable combinations of a primary gonadal defect and hypothalamic dysfunction
Eldar‐Geva, T., Hirsch, H. J., Benarroch, F., Rubinstein, O., & Gross‐Tsur, V. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0901 · Cited by 66
Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys
Abbott, D. H., Rayome, B. H., Dumesic, D. A., Lewis, K. C., Edwards, A. K., Wallen, K., Wilson, M. E., Appt, S. E., & Levine, J. E. (2017) · Human Reproduction · doi:10.1093/humrep/dex036 · Cited by 66
Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women
Duijkers, I. J. M., & Klipping, C. (2010) · Gynecological Endocrinology · doi:10.3109/09513590903247824 · Cited by 66
Hormonal Profile in Women with Polycystic Ovarian Syndrome with or without Type 1 Diabetes Mellitus
Ethel Codner, D., Íñiguez, G., Villarroel, C., López, P. V., Néstor Soto, I., Sir‐Petermann, T., CASSORLA, F. G., & Rey, R. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1252 · Cited by 65
Circulating Irisin and Glucose-Dependent Insulinotropic Peptide Are Associated With the Development of Polycystic Ovary Syndrome
Chang, C. L., Huang, S. Y., Soong, Y. K., Cheng, P. J., Wang, C., & Liang, I. T. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1180 · Cited by 68
Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology
Bayrak, A., Terbell, H., Urwitz‐Lane, R., Mor, E., Stanczyk, F. Z., & Paulson, R. J. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.08.096 · Cited by 64
Anti-müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis
van der Ham, K., Laven, J. S. E., Tay, C. T., Mousa, A., Teede, H. J., & Louwers, Y. V. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.05.163 · Cited by 79
Undetectable serum anti-Müllerian hormone levels and occurrence of ongoing pregnancy
Fraisse, T., Ibéchéole, V., Streuli, I., Bischof, P., & de Ziegler, D. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.03.084 · Cited by 63
Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization
Desforges-Bullet, V., Gallo, C., Lefebvre, C., Pigny, P., Dewailly, D., & Catteau-Jonard, S. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.004 · Cited by 61
Amh regulate female folliculogenesis and fertility in a dose-dependent manner through Amhr2 in Nile tilapia
Liu, X., Xiao, H., Jie, M., Dai, S., Wu, X., Li, M., & Wang, D. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110593 · Cited by 61
Controversies in the diagnosis of polycystic ovary syndrome
Rao, P., & Bhide, P. (2020) · Therapeutic Advances in Reproductive Health · doi:10.1177/2633494120913032 · Cited by 63
Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women
Duijkers, I. J. M., & Klipping, C. (2009) · Gynecological Endocrinology · doi:10.1080/09513590903247824 · Cited by 60
The influence of circulating anti-Müllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: a pilot study
Amer, S. A. K. S., Mahran, A., Abdelmaged, A., El-Adawy, A. R., Eissa, M. K., & Shaw, R. W. (2013) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-11-115 · Cited by 60
Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome
Fraser, G. L., Obermayer-Pietsch, B. M., Laven, J. S. E., Griesinger, G., Pintiaux, A., Timmerman, D., Fauser, B. C. J. M., Lademacher, C., Combalbert, J., Hoveyda, H. R., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab320 · Cited by 63
Serum müllerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome
Siow, Y., Kives, S. L., Hertweck, P., Perlman, S. E., & Fallat, M. E. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.02.052 · Cited by 59
Serum antimüllerian hormone in healthy premenopausal women
Shaw, C. M., Stanczyk, F. Z., Egleston, B. L., Kahle, L., Spittle, C. S., Godwin, A. K., Brinton, L. A., & Dorgan, J. F. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.05.051 · Cited by 59
Genomic heritability and genome-wide association analysis of anti-Müllerian hormone in Holstein dairy heifers
Nawaz, M. Y., Jimenez‐Krassel, F., Steibel, J. P., Lu, Y., Baktula, A. M., Vukasinovic, N., Neuder, L. M., Ireland, J. L. H., Ireland, J. J., & Tempelman, R. J. (2018) · Journal of Dairy Science · doi:10.3168/jds.2018-14798 · Cited by 58
The Use of Anti-Mullerian Hormone in Predicting Menstrual Response after Weight Loss in Overweight Women with Polycystic Ovary Syndrome
Moran, L., Noakes, M., Clifton, P. M., & Norman, R. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1188 · Cited by 58
Effects of resveratrol on growth and function of rat ovarian granulosa cells
Ortega, I., Wong, D. H., Villanueva, J. A., Cress, A. B., Sokalska, A., Stanley, S. D., & Dulęba, A. J. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.08.004 · Cited by 57
Anti-Müllerian hormone (AMH) in the Diagnosis of Menstrual Disturbance Due to Polycystic Ovarian Syndrome
Abbara, A., Eng, P. C., Phylactou, M., Clarke, S. A., Hunjan, T., Roberts, R. E., Vimalesvaran, S., Christopoulos, G., Islam, R., Purugganan, K., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00656 · Cited by 67
Diagnostic Criteria for Polycystic Ovarian Syndrome
Broekmans, F. J., & Fauser, B. C. J. M. (2006) · Endocrine · doi:10.1385/endo:30:1:3 · Cited by 56
High serum Antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology
Tal, R., Seifer, C. M., Khanimov, M., Seifer, D. B., & Tal, O. (2020) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-020-00581-4 · Cited by 57
The excess in 2–5 mm follicles seen at ovarian ultrasonography is tightly associated to the follicular arrest of the polycystic ovary syndrome
Dewailly, D., Catteau-Jonard, S., Reyss, A.-C., Maunoury-Lefebvre, C., Poncelet, É., & Pigny, P. (2007) · Human Reproduction · doi:10.1093/humrep/dem060 · Cited by 55
Ovarian imaging by magnetic resonance in adolescent girls with polycystic ovary syndrome and age‐matched controls
Brown, M., Park, A. S., Shayya, R. F., Wolfson, T., Su, H. I., & Chang, R. J. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23992 · Cited by 54
Antimüllerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate
Mohamed, K. A., Davies, W. A., & Lashen, H. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.047 · Cited by 55
Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles
Dewailly, D., Alebi, M., Duhamel, A., & Stojanovi, N. (2014) · Human Reproduction · doi:10.1093/humrep/deu242 · Cited by 55
Anti-Müllerian hormone in obese adolescent girls with polycystic ovary syndrome
Kim, J. Y., Tfayli, H., Michaliszyn, S. F., Lee, S., Nasr, A., & Arslanian, S. (2017) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2016.10.015 · Cited by 54
Common diseases as determinants of menopausal age
Li, J., Eriksson, M., Czene, K., Hall, P. N., & Rodriguez‐Wallberg, K. A. (2016) · Human Reproduction · doi:10.1093/humrep/dew264 · Cited by 54
Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women
Yue, C., Lu, L., Li, M., Zhang, Q., & Ying, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203129 · Cited by 53
Serum antimüllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproduction
Kaya, C., Pabuçcu, R., & Şatıroğlu, H. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.12.002 · Cited by 52
The clinical significance of anti-Müllerian hormone evaluation in gynecological endocrinology
Karkanaki, A., Vosnakis, C., & Panidis, D. (2011) · HORMONES · doi:10.14310/horm.2002.1299 · Cited by 52
Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women
Jung, S., Allen, N. E., Arslan, A. A., Baglietto, L., Brinton, L. A., Egleston, B. L., Falk, R. T., Fortner, R. T., Helzlsouer, K. J., Idahl, A., et al. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.02.105 · Cited by 52
Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome
Köninger, A., Koch, L., Edimiris, P., Enekwe, A., Nagarajah, J., Kasimir‐Bauer, S., Kimmig, R., Strowitzki, T., & Schmidt, B. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3317-2 · Cited by 51
The role of serum anti-Müllerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome
Casadei, L., Madrigale, A., Puca, F., Manicuti, C., Emidi, E., Piccione, E., & Dewailly, D. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.777415 · Cited by 51

Authors: Pigny, P., Merlen, E., Robert, Y., Cortet-Rudelli, C., Decanter, C., Jonard, S., & Dewailly, D.
Affiliations: Laboratory of Endocrinology (P.P.), 59037 Lille, France;
Clinique Marc Linquette; Departments of Endocrine Gynaecology and Reproductive Medicine (E.M., C.D., S.J., D.D.), 59037 Lille, France;
Hôpital Jeanne de Flandre (FR)
Department of Diabetology and Endocrinology (C.C.-R.), Centre Hospitalier Régional Universitaire de Lille, 59037 Lille, France
Corresponding author: Dewailly, Didier
ORCID: Pigny, Pascal
Decanter, Christine
Dewailly, Didier
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2003-12-01
Volume: 88
Issue: 12
Pages: 5957-5962
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jc.2003-030727
OpenAlex: W2153731002
Cited by: 709
References: 28
Citations by year: 2026: 18 · 2025: 20 · 2024: 34 · 2023: 25 · 2022: 45 · 2021: 45 · 2020: 30 · 2019: 41 · 2018: 38 · 2017: 37 · 2016: 47 · 2015: 33 · 2014: 37 · 2013: 43 · 2012: 38
FWCI: 10.40
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
Keywords: anti-Müllerian hormone, polycystic ovary syndrome, antral follicle count, follicle-stimulating hormone, testosterone, androstenedione, granulosa cells, ovarian reserve, folliculogenesis, ovarian ultrasonography, inhibin B, estradiol, luteinizing hormone, progestins
MeSH terms: Adult, Female, Glycoproteins, Ovarian Follicle, Hormones, Humans, Immunoassay, Obesity, Polycystic Ovary Syndrome, Testicular Hormones, Ultrasonography, Case-Control Studies, Anti-Mullerian Hormone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Elevated Serum Level of Anti-Mullerian Hormone in Patients with Polycystic Ovary Syndrome: Relationship to the Ovarian Follicle Excess and to the Follicular Arrest

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks